AHA/ACC preventive cardiology, dyslipidemia & epi (Lp(a)/LDL goals, PREVENT, menopause, visceral fat HF); aggressive LDL<55 cuts MACE 33%; HTN advances; new chol guidelines; obicetrapib; small daily changes+irregular sleep+neuro risks
Key Questions
What MACE reduction is associated with aggressive LDL lowering?
Aggressive LDL targets below 55 mg/dL cut major adverse cardiovascular events (MACE) by 33%, as shown in Ez-PAVE NEJM RCT with fewer MI and revascularizations in ASCVD.
What are the new recommendations for Lp(a) management?
Lp(a) receives COR1 recommendation with ongoing Phase 3 trials. It is a key focus in dyslipidemia guidelines alongside LDL, ApoB, FH, LMHR, and CAC.
How does irregular sleep affect heart risk?
Irregular bedtimes double MACE risk for those sleeping under 8 hours, based on 10-year follow-up of 3,000 people. Consistent sleep timing below 8 hours significantly raises cardiovascular risk.
What midlife vitamin D level protects brain health?
Vitamin D levels above 30 ng/mL in midlife lower tau accumulation by 16 years later. This supports long-term neuroprotection against dementia.
Did high-dose flu vaccine reduce Alzheimer's risk?
Older adults receiving high-dose flu shots had 20% lower Alzheimer's risk per MGH study. This links vaccination to reduced neurodegenerative risk.
What are the safety results of obicetrapib?
Obicetrapib was safe and well-tolerated in Phase 3 for HeFH and ASCVD patients. It offers a new option in dyslipidemia management.
How do small daily changes impact CV risk?
Small daily increases in sleep, MVPA, and vegetables cut heart attack and stroke risk. AHA endorses nine diet patterns and Japanese habits for prevention.
What are the key updates in US cholesterol guidelines?
New guidelines emphasize early FH treatment, PREVENT strategies with statins/PCSK9/PGx/IPE, and LDL<55 goals. They integrate multimorbidity, menopause, visceral fat, and HTN advances.
ACC26/AHA chol FH early/PREVENT/LDL<55 slash MACE Ez-PAVE NEJM RCT ASCVD fewer MI/revasc; Lp(a) COR1/P3s; dyslip/FH/LMHR/CAC/ApoB; PREVENT statin/PCSK9/PGx/IPE; multimorb BP; irregular bedtimes double MACE <8hrs 3k 10yr FU; midlife vitD>30ng/mL lower tau 16y; high-dose flu vax 20% lower AD MGH; SBP<130 midlife dementia prev; AHA nine diet/Japanese habits; small daily sleep/MVPA/veg CV cut; obicetrapib Ph3 safe; menopause/visceral HF; zilebesiran/SGLT2; tonlamarsen; cold seniors; HF ketones EF boost.